Home    Back

Intravenous injection autologous mesenchymal stem cells    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
67Polycystic kidney disease1

67. Polycystic kidney disease    [ 186 clinical trials,   196 drugs,   (DrugBank: 47 drugs),   35 drug target genes,   146 drug target pathways]
Searched query = "Polycystic kidney disease", "PKD", "PCKD", "Polycystic kidney", "ADPKD", "ARPKD"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 186 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02166489
(ClinicalTrials.gov)		March 201414/6/2014Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney DiseaseEvaluation the Effect of Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Autosomal Dominant Polycystic Kidney DiseaseChronic Renal Failure;Polycystic Kidney DiseaseBiological: Intravenous injection autologous mesenchymal stem cellsRoyan InstituteNULLCompleted18 Years60 YearsBoth6Phase 1Iran, Islamic Republic of